{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:33Z","timestamp":1761630513017},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2344,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1111\/j.1365-2230.2008.02922.x","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T14:01:35Z","timestamp":1236866495000},"page":"380-384","source":"Crossref","is-referenced-by-count":12,"title":["Nicotinamide and its metabolite<i>N-<\/i>methylnicotinamide increase skin vascular permeability in rats"],"prefix":"10.1093","volume":"34","author":[{"given":"L.","family":"Pietrzak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mogielnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Buczko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-4362.1995.tb04449.x","article-title":"Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris","volume":"34","author":"Shalita","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB2","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.mehy.2004.11.019","article-title":"Nicotinamide trials in diabetes intervention. Does a metabolite provide benefit?","volume":"64","author":"Gosteli","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2230.2005.01908.x","article-title":"Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study","volume":"30","author":"Wozniacka","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2249.2003.02031.x","article-title":"Nicotinamide is a potent inhibitor of proinflammatory cytokines","volume":"131","author":"Ungerstedt","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB5","first-page":"109","article-title":"1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin","volume":"55","author":"Gebicki","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000057762","article-title":"Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury","volume":"39","author":"Chong","year":"2002","journal-title":"J Vasc Res"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3727\/0965040042380478","article-title":"Nicotinamide relaxes vascular smooth muscle by inhibiting myosin light chain kinase-dependent signaling pathways: implications for anticancer efficacy","volume":"14","author":"Ruddock","year":"2004","journal-title":"Oncol Res"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1055\/s-0038-1646066","article-title":"Guidelines for the use of animals in biomedical research","volume":"58","author":"Giles","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3181\/00379727-133-34695","article-title":"Simple method for quantitation of enhanced vascular permeability","volume":"133","author":"Udaka","year":"1970","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB10","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.HYP.0000035396.27909.40","article-title":"Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7)","volume":"40","author":"Kucharewicz","year":"2002","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-201X.1996.457174000.x","article-title":"Tachykinins increase vascular permeability in the gastrointestinal tract of the rat","volume":"156","author":"Lordal","year":"1996","journal-title":"Acta Physiol Scand"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1440-1843.2004.00556.x","article-title":"Methylprednisolone reduces airway microvascular permeability but not airway resistance induced by N-formylmethionine leucyl-phenylalanine in the rabbit","volume":"9","author":"Matheson","year":"2004","journal-title":"Respirology"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-0038-1647964","article-title":"Biological properties of dialysable peptides derived from plasmin digestion of bovine fibrinogen preparations","volume":"35","author":"Buczko","year":"1976","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1476-5381.1980.tb07902.x","article-title":"Biological effects of degradation products of collagen by bacterial collagenase","volume":"69","author":"Buczko","year":"1980","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0041-008X(83)90188-6","article-title":"Characteristics of nicotinamide and N1-methylnicotinamide protection from alloxan diabetes in mice","volume":"70","author":"Fischer","year":"1983","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/246215a0","article-title":"Prostaglandins as potentiators of increased vascular permeability in inflammation","volume":"246","author":"Williams","year":"1973","journal-title":"Nature"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/PL00005079","article-title":"Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin","volume":"356","author":"Fujii","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.CIR.97.1.99","article-title":"Vascular endothelial growth factor\/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin","volume":"97","author":"Murohara","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(95)00758-X","article-title":"Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin","volume":"297","author":"Fujii","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.bjp.0703277","article-title":"Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide","volume":"130","author":"Fujii","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(83)90588-3","article-title":"Prostacyclin production augmented in the short term by nicotinic acid","volume":"2","author":"Olsson","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB22","first-page":"241","article-title":"Thrombolytic and antiplatelet action of xanthinol nicotinate (Sadamin): possible mechanisms","volume":"49","author":"Bieron","year":"1998","journal-title":"J Physiol Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.bjp.0707383","article-title":"1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2\/prostacyclin pathway","volume":"152","author":"Chlopicki","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB24","first-page":"515","article-title":"N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats","volume":"58","author":"Mogielnicki","year":"2007","journal-title":"J Physiol Pharmacol"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB25","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0024-3205(97)00808-4","article-title":"Nicotinamide inhibits inducible nitric oxide synthase enzyme activity in macrophages by allowing nitric oxide to inhibit its own formation","volume":"61","author":"Andrade","year":"1997","journal-title":"Life Sci"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2006-924966","article-title":"Nicotinamide increases thyroid radiosensitivity by stimulating nitric oxide synthase expression and the generation of organic peroxides","volume":"38","author":"Agote Robertson","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1111\/j.1365-2230.2008.02922.x-BIB27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1179\/135100099101534882","article-title":"Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria","volume":"4","author":"Kamat","year":"1999","journal-title":"Redox Rep"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2008.02922.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2008.02922.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:26:23Z","timestamp":1676384783000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/3\/380\/6624629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2008.02922.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}